Medical Devices Update
18 January 2023 | 4:00 PM - 5:30 PM (CET)
We are pleased to invite you to our Medical Devices Update Webinar on Wednesday, 18 January 2023.
Biotech Showcase and exclusive reception during the J.P. Morgan 41st Annual Healthcare Conference
9-12 January 2023
On 9-12 January 2023, Hogan Lovells is a sponsor at the Biotech Showcase. Alice Valder Curran, Jodi Scott, and Andrew Strong will present at the conference.
ASHP Midyear Conference
06 December 2022 | 2:00 - 4:00 p.m. (PT)
Beth R. Roberts presented on “2023 Payment Rules for Drugs and Services: Impacting Your Pharmacy!”
GCR Live: Antitrust in Pharmaceuticals
1 December 2022
Ilana Kattan was invited to speak on a panel titled “Merger control strategies: Managing risks in an uncertain regulatory environment” on 1 December 2022.
Dinner, drinks, and discussion on the impacts of the Inflation Reduction Act of 2022
01 December 2022 | 05:30 PM - Registration and cocktails | 06:30 PM - Dinner and discussion (EST)
We invite you to a cocktail reception and dinner with the Hogan Lovells Life Sciences and Health Care team on Thursday, December 1 at The Royal Sonesta in Cambridge.
APAC Life Sciences and Health Care Webinar Series - Spotlight on Greater China - Session 4
16 November 2022 | 8:30 a.m. - 9:45 a.m. CET| 3:30 p.m. - 4:45 p.m. CST/HKT | 4:30 p.m. - 5:45 p.m. JST
Webinar No. 4: Life Sciences companies navigating the shifting patent landscape in China
Unpacking the prescription drug provisions of the Inflation Reduction Act of 2022
13 &15 September 2022: 12:00 PM - 1:30 PM EDT | 20 September 2022: 12:00 PM - 1:00 PM EDT
On 7 August, 2022, the Senate passed the proposed Inflation Reduction Act of 2022, which includes a number of significant prescription drug-related provisions. The bill generally revives...
APAC Life Sciences and Health Care Webinar Series - Spotlight on Greater China
17 May 2022 - 16 November 2022
Companies in the life sciences and health care industry continue to navigate unparalleled challenges during the COVID-19 pandemic while also seeking to balance commercial opportunities and...
